623 related articles for article (PubMed ID: 7670532)
1. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
Kierszenbaum F; Moretti E; Sztein MB
Biol Res; 1993; 26(1-2):197-207. PubMed ID: 7670532
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
Sztein MB; Cuna WR; Kierszenbaum F
J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Trypanosoma cruzi-induced down-regulation of lymphocyte function. Inhibition of transcription and expression of IL-2 receptor gamma (p64IL-2R) and beta (p70IL-2R) chain molecules in activated normal human lymphocytes.
Majumder S; Kierszenbaum F
J Immunol; 1996 May; 156(10):3866-74. PubMed ID: 8621925
[TBL] [Abstract][Full Text] [Related]
4. Trypanosomal immunosuppressive factor: a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cells.
Kierszenbaum F; Cuna WR; Beltz LA; Sztein MB
J Immunol; 1990 May; 144(10):4000-4. PubMed ID: 2185317
[TBL] [Abstract][Full Text] [Related]
5. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production.
Van Voorhis WC
J Immunol; 1992 Jan; 148(1):239-48. PubMed ID: 1727869
[TBL] [Abstract][Full Text] [Related]
6. Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression.
Beltz LA; Sztein MB; Kierszenbaum F
J Immunol; 1988 Jul; 141(1):289-94. PubMed ID: 3132504
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi reduces the number of high-affinity IL-2 receptors on activated human lymphocytes by suppressing the expression of the p55 and p70 receptor components.
Kierszenbaum F; Cuna WR; Beltz LA; Sztein MB
J Immunol; 1989 Jul; 143(1):275-9. PubMed ID: 2659667
[TBL] [Abstract][Full Text] [Related]
8. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.
Sztein MB; Kierszenbaum F
Immunology; 1992 Oct; 77(2):277-83. PubMed ID: 1427979
[TBL] [Abstract][Full Text] [Related]
9. A soluble factor from Trypanosoma brucei rhodesiense that prevents progression of activated human T lymphocytes through the cell cycle.
Sztein MB; Kierszenbaum F
Immunology; 1991 Jun; 73(2):180-5. PubMed ID: 2071163
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.
Kierszenbaum F; Lopez HM; Sztein MB
Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517
[TBL] [Abstract][Full Text] [Related]
11. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules.
Ernst DN; Weigle WO; McQuitty DN; Rothermel AL; Hobbs MV
J Immunol; 1989 Mar; 142(5):1413-21. PubMed ID: 2521878
[TBL] [Abstract][Full Text] [Related]
13. Selective suppressive effects of Trypanosoma cruzi infection on IL-2, c-myc, and c-fos gene expression.
Soong L; Tarleton RL
J Immunol; 1992 Sep; 149(6):2095-102. PubMed ID: 1517573
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytes.
Finkelman FD; Malek TR; Shevach EM; Mond JJ
J Immunol; 1986 Oct; 137(7):2252-9. PubMed ID: 3093569
[TBL] [Abstract][Full Text] [Related]
15. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
Tao X; Davis LS; Hashimoto K; Lipsky PE
J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
[TBL] [Abstract][Full Text] [Related]
16. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily.
Millar AE; Kahn SJ
Exp Parasitol; 2000 Feb; 94(2):84-91. PubMed ID: 10673344
[TBL] [Abstract][Full Text] [Related]
17. The acquisition of cytokine responsiveness by murine B cells: a role for antigen and IL-5 in the induction of IL-2 receptors.
Poudrier J; Owens T
Immunology; 1994 Mar; 81(3):373-80. PubMed ID: 8206511
[TBL] [Abstract][Full Text] [Related]
18. Involvement of soluble mediator(s) different from interleukin (IL) 1 in the antigen-induced IL 2 receptor expression and proliferation of L3T4+ (CD4+) T lymphocytes.
Germann T; Schmitt E; Huhn H; Rüde E
Eur J Immunol; 1988 Mar; 18(3):459-65. PubMed ID: 3128448
[TBL] [Abstract][Full Text] [Related]
19. Treponema denticola immunoinhibitory protein induces irreversible G1 arrest in activated human lymphocytes.
Lee W; Pankoski L; Zekavat A; Shenker BJ
Oral Microbiol Immunol; 2004 Jun; 19(3):144-9. PubMed ID: 15107064
[TBL] [Abstract][Full Text] [Related]
20. Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes.
Beltz LA; Kierszenbaum F; Sztein MB
Infect Immun; 1989 Aug; 57(8):2301-5. PubMed ID: 2663720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
